BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15670649)

  • 1. Guanine nucleotide depletion induces differentiation and aberrant neurite outgrowth in human dopaminergic neuroblastoma lines: a model for basal ganglia dysfunction in Lesch-Nyhan disease.
    Messina E; Micheli V; Giacomello A
    Neurosci Lett; 2005 Feb; 375(2):97-100. PubMed ID: 15670649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neural stem cells: a model system for the study of Lesch-Nyhan disease neurological aspects.
    Cristini S; Navone S; Canzi L; Acerbi F; Ciusani E; Hladnik U; de Gemmis P; Alessandri G; Colombo A; Parati E; Invernici G
    Hum Mol Genet; 2010 May; 19(10):1939-50. PubMed ID: 20159777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the dopamine defect in primary cultures of dopaminergic neurons from hypoxanthine phosphoribosyltransferase knockout mice.
    Smith DW; Friedmann T
    Mol Ther; 2000 May; 1(5 Pt 1):486-91. PubMed ID: 10933970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the adenosinergic system in the brain of HPRT knockout mouse (Lesch-Nyhan disease).
    Bertelli M; Cecchin S; Lapucci C; Jacomelli G; Jinnah HA; Pandolfo M; Micheli V
    Clin Chim Acta; 2006 Nov; 373(1-2):104-7. PubMed ID: 16793031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients.
    Fairbanks LD; Jacomelli G; Micheli V; Slade T; Simmonds HA
    Biochem J; 2002 Aug; 366(Pt 1):265-72. PubMed ID: 11996669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered membrane NTPase activity in Lesch-Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT-deficient cell lines.
    Pinto CS; Jinnah HA; Shirley TL; Nyhan WL; Seifert R
    J Neurochem; 2005 Jun; 93(6):1579-86. PubMed ID: 15935074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis.
    Ceballos-Picot I; Mockel L; Potier MC; Dauphinot L; Shirley TL; Torero-Ibad R; Fuchs J; Jinnah HA
    Hum Mol Genet; 2009 Jul; 18(13):2317-27. PubMed ID: 19342420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is ZMP the toxic metabolite in Lesch-Nyhan disease?
    López JM
    Med Hypotheses; 2008 Nov; 71(5):657-63. PubMed ID: 18710792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemical basis of the neurobehavioral abnormalities in the Lesch-Nyhan syndrome: a hypothesis.
    Neychev VK; Mitev VI
    Med Hypotheses; 2004; 63(1):131-4. PubMed ID: 15193365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.
    Jinnah HA; Langlais PJ; Friedmann T
    J Pharmacol Exp Ther; 1992 Nov; 263(2):596-607. PubMed ID: 1432691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired differentiation of HPRT-deficient dopaminergic neurons: a possible mechanism underlying neuronal dysfunction in Lesch-Nyhan syndrome.
    Yeh J; Zheng S; Howard BD
    J Neurosci Res; 1998 Jul; 53(1):78-85. PubMed ID: 9670994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human neuronal tissue culture model for Lesch-Nyhan disease.
    Shirley TL; Lewers JC; Egami K; Majumdar A; Kelly M; Ceballos-Picot I; Seidman MM; Jinnah HA
    J Neurochem; 2007 May; 101(3):841-53. PubMed ID: 17448149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiopathology of neurological signs of hypoxanthine-guanine phosphoribosyltransferase deficiency].
    Torres-Jiménez R; Mateos-Antón F; Arcas-Martínez J; Pascual-Castroviejo I; García-Puig J
    Rev Neurol; 1998 Dec; 27(160):1050-4. PubMed ID: 9951034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased GTP-stimulated adenylyl cyclase activity in HPRT-deficient human and mouse fibroblast and rat B103 neuroblastoma cell membranes.
    Pinto CS; Seifert R
    J Neurochem; 2006 Jan; 96(2):454-9. PubMed ID: 16336632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesch-Nyhan syndrome: the synthesis of inosine 5'-phosphate in the hypoxanthine-guanine phosphoribosyltransferase-deficient erythrocyte by alternate biochemical pathways.
    Lowy BA; Williams MK
    Pediatr Res; 1977 May; 11(5):691-4. PubMed ID: 870876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxanthine-guanine phosphoribosyltransferase-deficiency produces aberrant neurite outgrowth of rodent neuroblastoma used to model the neurological disorder Lesch Nyhan syndrome.
    Connolly GP
    Neurosci Lett; 2001 Nov; 314(1-2):61-4. PubMed ID: 11698147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanine nucleotide depletion triggers cell cycle arrest and apoptosis in human neuroblastoma cell lines.
    Messina E; Gazzaniga P; Micheli V; Guaglianone MR; Barbato S; Morrone S; Frati L; Aglianò AM; Giacomello A
    Int J Cancer; 2004 Mar; 108(6):812-7. PubMed ID: 14712481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of mycophenolate mofetil in the management of neuroblastoma patients.
    Messina E; Barile L; Lupi F; Giacomello A
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1545-9. PubMed ID: 15571295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial characterization of the proteome of the mouse striatum.
    Guo LT; Friedmann T; King CC
    Proteomics; 2007 Nov; 7(21):3867-9. PubMed ID: 17922512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.